Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210287281> ?p ?o ?g. }
- W3210287281 endingPage "2340" @default.
- W3210287281 startingPage "2330" @default.
- W3210287281 abstract "The aim of this AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease) trial subgroup analysis was to examine rivaroxaban monotherapy benefits and their relation to the time between stenting and enrollment among patients after coronary stenting.Of 2,215 patients with atrial fibrillation and stable coronary artery disease in the AFIRE trial, rivaroxaban monotherapy was noninferior to rivaroxaban plus antiplatelet therapy (combination therapy) in terms of efficacy and superior for safety endpoints. However, thrombotic risk after antiplatelet therapy cessation remained a concern among 1,444 patients who had undergone coronary stenting >1 year before enrollment.The benefits of rivaroxaban monotherapy in coronary stenting subgroups were assessed for efficacy (a composite of stroke, systemic embolism, myocardial infarction, unstable angina requiring revascularization, or death of any cause), safety (major bleeding defined according to International Society on Thrombosis and Haemostasis criteria), ischemic endpoints, net adverse clinical event, and time between stenting and enrollment.Efficacy and safety endpoints for monotherapy were superior to combination therapy, with HRs of 0.70 for efficacy (95% CI: 0.50-0.98; P = 0.036) and 0.55 for safety (95% CI: 0.33-0.92; P = 0.019). For ischemic endpoints, the HR was 0.82 (95% CI: 0.58-1.15; P = 0.240). The HR became smaller with longer time between stenting and enrollment (efficacy, P for interaction = 0.158; safety, P = 0.097).In patients with atrial fibrillation after coronary stenting, the benefits of rivaroxaban monotherapy for efficacy and safety endpoints were consistent with those in the whole AFIRE trial population. The benefits became apparent with longer time between stenting and enrollment. (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease Study [AFIRE]; UMIN000016612, NCT02642419)." @default.
- W3210287281 created "2021-11-08" @default.
- W3210287281 creator A5000322274 @default.
- W3210287281 creator A5000478646 @default.
- W3210287281 creator A5000528736 @default.
- W3210287281 creator A5001421629 @default.
- W3210287281 creator A5001618675 @default.
- W3210287281 creator A5001716953 @default.
- W3210287281 creator A5002800933 @default.
- W3210287281 creator A5002871488 @default.
- W3210287281 creator A5003078655 @default.
- W3210287281 creator A5003492839 @default.
- W3210287281 creator A5003552934 @default.
- W3210287281 creator A5003580258 @default.
- W3210287281 creator A5003665780 @default.
- W3210287281 creator A5003833126 @default.
- W3210287281 creator A5004090521 @default.
- W3210287281 creator A5004909684 @default.
- W3210287281 creator A5005952657 @default.
- W3210287281 creator A5006004590 @default.
- W3210287281 creator A5006441304 @default.
- W3210287281 creator A5006456194 @default.
- W3210287281 creator A5007102813 @default.
- W3210287281 creator A5007580598 @default.
- W3210287281 creator A5007777733 @default.
- W3210287281 creator A5008109174 @default.
- W3210287281 creator A5008238844 @default.
- W3210287281 creator A5008300878 @default.
- W3210287281 creator A5008506790 @default.
- W3210287281 creator A5008640477 @default.
- W3210287281 creator A5009234920 @default.
- W3210287281 creator A5009341829 @default.
- W3210287281 creator A5009668342 @default.
- W3210287281 creator A5009760063 @default.
- W3210287281 creator A5009824386 @default.
- W3210287281 creator A5010345896 @default.
- W3210287281 creator A5010491253 @default.
- W3210287281 creator A5010588865 @default.
- W3210287281 creator A5010606352 @default.
- W3210287281 creator A5011212046 @default.
- W3210287281 creator A5011239209 @default.
- W3210287281 creator A5011399496 @default.
- W3210287281 creator A5011453870 @default.
- W3210287281 creator A5011834257 @default.
- W3210287281 creator A5011996744 @default.
- W3210287281 creator A5012330250 @default.
- W3210287281 creator A5012443421 @default.
- W3210287281 creator A5012852821 @default.
- W3210287281 creator A5013132867 @default.
- W3210287281 creator A5013214049 @default.
- W3210287281 creator A5013703823 @default.
- W3210287281 creator A5013837317 @default.
- W3210287281 creator A5013916436 @default.
- W3210287281 creator A5013972463 @default.
- W3210287281 creator A5014255771 @default.
- W3210287281 creator A5014759209 @default.
- W3210287281 creator A5014963730 @default.
- W3210287281 creator A5015152835 @default.
- W3210287281 creator A5015234418 @default.
- W3210287281 creator A5015358446 @default.
- W3210287281 creator A5016181249 @default.
- W3210287281 creator A5016825995 @default.
- W3210287281 creator A5017724039 @default.
- W3210287281 creator A5017863780 @default.
- W3210287281 creator A5017935863 @default.
- W3210287281 creator A5018314623 @default.
- W3210287281 creator A5018410857 @default.
- W3210287281 creator A5018539336 @default.
- W3210287281 creator A5019801474 @default.
- W3210287281 creator A5020090012 @default.
- W3210287281 creator A5020197601 @default.
- W3210287281 creator A5020485724 @default.
- W3210287281 creator A5021306750 @default.
- W3210287281 creator A5021523855 @default.
- W3210287281 creator A5021850885 @default.
- W3210287281 creator A5022030714 @default.
- W3210287281 creator A5022125728 @default.
- W3210287281 creator A5022381267 @default.
- W3210287281 creator A5022889313 @default.
- W3210287281 creator A5023118044 @default.
- W3210287281 creator A5023570449 @default.
- W3210287281 creator A5023792530 @default.
- W3210287281 creator A5023895524 @default.
- W3210287281 creator A5024016286 @default.
- W3210287281 creator A5024129386 @default.
- W3210287281 creator A5024161005 @default.
- W3210287281 creator A5024202791 @default.
- W3210287281 creator A5024278402 @default.
- W3210287281 creator A5024349883 @default.
- W3210287281 creator A5024593674 @default.
- W3210287281 creator A5024856942 @default.
- W3210287281 creator A5025068626 @default.
- W3210287281 creator A5025364801 @default.
- W3210287281 creator A5026031312 @default.
- W3210287281 creator A5027056390 @default.
- W3210287281 creator A5027424299 @default.
- W3210287281 creator A5027904594 @default.
- W3210287281 creator A5027936001 @default.